Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
Clinical trial NCT07298343 · RECRUITING
Trial details
- NCT number
- NCT07298343
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2027-08-01
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.